** Genpact G.N up 11.6% to $55.13 after hitting record high of $56.76 and on track for biggest daily pct gain since Aug 9
** The professional services company reported Q4 adj EPS and revenue that topped Street estimates after the close on Thursday while also giving its Q1 and FY 2025 outlook
** BMO raised its price target on the stock to $58 from $53 but kept its "market perform" rating intact, noting the FY2025 guidance "appears prudent" but the firm said it still questions the durability of growth longer term.
** Jefferies equity analyst Surinder Third reiterated "buy" rating, said, "Many of the strategic changes implemented earlier in the year appear to have coalesced, which leads us to believe growth has the potential to show further improvement in 2025."
** Needham raised its price target on the stock to $65 from $55 per share
** Of 11 analysts covering Genpact Ltd, breakdown of recommendations are 5 "strong buy" or "buy" and 6 "hold" ratings
** Median price target of $57 is up from $48 a month ago and from $41 on Nov 7
(Reporting by Chuck Mikolajczak)
((charles.mikolajczak@tr.com; @ChuckMik;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。